Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SFP Dose Ranging in ESRD Hemodialysis
NCT00548249Phase 2Completed
- Sponsor
- Rockwell Medical
- Start
- Aug 2007
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of ferric pyrophosphate in anemia of chronic kidney disease (CKD-A), sponsored by Rockwell Medical. Started Aug 2007; status: completed.
02
Drugs
ferric pyrophosphate
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00548249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548249.